Session 22: Fermentation/Cell Culture: Biologics: Delivering Innovation to Industry and Patients Alike
Thursday, August 6, 2015: 8:00 AM-11:30 AM
Freedom Ballroom, Mezzanine Level (Sheraton Philadelphia Downtown Hotel)
Convener:
Blum David - University of Georgia, Athens, GA
Co-Convener:
Tiffany D. Rau - Consultant, Lake Charles, LA


8:00 AM
S110
A bioprocess control system to automate and optimize nutrient feeding protocols
George Barringer1, Greg Emmerson2 and Sam Watts2, (1)Stratophase Ltd (USA), W Groton, MA, (2)Stratophase Ltd, Romsey, United Kingdom
8:30 AM
S111
In situ and Real-time Monitoring of Multiple Biochemicals During Microbial Process Development Utilizing Raman Spectroscopy
Juan Aon1, Sean Gilliam2, Jianxin Sun3, Ricardo Tecson3, Vani Patel3 and David Strachan2, (1)Microbial and Cell Culture Development, GlaxoSmithKline, King of Prussia, PA, (2)Kaiser, Ann Arbor, MI, (3)GlaxoSmithKline, King of Prussia, PA
9:00 AM
S112
Discovering and Developing Antibodies against Difficult Targets
Benjamin Doranz, Integral Molecular, Philadelphia, PA
Doranz SIMB.pdf
9:30 AM
Break
10:00 AM
S113
Recent advances in optical methods of biomass monitoring
Martin P. Debreczeny, BugLab, LLC, Concord, CA
10:30 AM
S114
Methods and Processes for Transient Protein Production to Support Early Stage Protein Therapeutic Development.
Dr. Barry Morse, Biologics Research, Janssen R&D, Spring House, PA
11:00 AM
S115
Rapid Process Development Enabled by Automated, Single Use High Throughput Technologies
Nikhil Ramsubramaniam, Bioprocess Technology and Expression, Bioprocess Development, Merck and Company, Kenilworth, NJ
See more of: Invited Oral Papers
<< Previous Session | Next Session >>